On Wednesday, July 11th, 2018 Strainprint President & CTO, David Berg, and COO of Emblem Cannabis Corp, Adam Saperia had the opportunity to appear on the Humble & Fred Radio show where they talked about the benefits of medical cannabis, patient tracking and how data is helping to shape the future of the cannabis industry.
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]
As part of our recent launch of Strainprint Analytics or President & CEO were interviewed by Business of Cannabis. Learn what they had to say about the launch here: https://www.businessofcannabis.ca/2018/03/28/bofc-quick-hits-with-strainprint/
PRESS RELEASE: TORONTO, March 28, 2018 /CNW/ – Strainprint, the leader in cannabis data collection and strain efficacy reporting, is thrilled to announce the launch of Strainprint Analytics, a powerful web-based data platform for visually mining the world’s largest data set on strain efficacy and real-time patient use. On March 27, Strainprint gathered with key […]
Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post, share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine